Clinical Trial

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

Completed Phase 4
View on ClinicalTrials.gov →
Summary
This study is being completed to determine if 8 weeks of treatment with imiquimod can shrink sebaceous hyperplasia.
Protocol Amendment History 6 changes
critical Trial completed 2026-08-12
notable Enrollment reduced: 40 -> 11 participants 2026-08-12
minor Completion moved earlier: 2027-01-31 -> 2026-04-08 2026-08-12
notable Primary completion moved earlier: 2026-12-31 -> 2026-04-08 2026-08-08
notable Primary completion pushed: 2026-05-06 -> 2026-12-31 2026-07-17
minor Completion pushed: 2026-05-31 -> 2027-01-31 2026-07-17
Trial Details
NCT Number NCT06840470
Lead Sponsor University of Michigan
Conditions Sebaceous Hyperplasia
Enrollment 11 participants
Start Date 2025-03-11
Primary Completion 2026-04-08 (estimated)
Study Completion 2026-04-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-11